HLC Opposes Expansion of TRIPS Intellectual Property Waiver to COVID-19 Diagnostics and Therapeutics

March 29, 2023

In Statement to U.S. International Trade Commission, Health Leaders Say Medical Innovation Likely to “Suffer and Shrink” by Weakening Protections WASHINGTON – In a statement to the U.S. International Trade … Continued

HLC Recommends Adjustments to Proposed Medicare Advantage Rate Cuts to Preserve Quality Patient Care

March 6, 2023

In Letter to CMS, Health Leaders Also Cite Ramifications of Proposed Changes in Diagnosis Coding That Could Impact Health Outcomes WASHINGTON – A proposed reduction in federal payments to Medicare … Continued

Health Leaders Welcome Opportunity to Work with House Energy and Commerce Committee to Improve Disaster Readiness

March 1, 2023

Healthcare Leadership Council Applauds Bipartisan Approach by Representatives Hudson, Eshoo on Key Reauthorization Bill WASHINGTON – An association of health industry leaders is praising U.S. Representatives Richard Hudson (R-NC) and … Continued